FDA Inspection 1304728 — Wilber W. Su, MD

Wilber W. Su, MD — FEI 3015983165

The FDA completed an inspection of Wilber W. Su, MD on Feb 27, 2026 in Phoenix, AZ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 27, 2026
Fiscal Year
2026
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Phoenix, AZ (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
296821 CFR 812.100Investigator non-compliance with agreement/plan/regulations

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.